US Patent

US9839619 — Method for treating ADD or ADHD comprising administering amphetamine complexed with ion-exchange resin particles

Formulation · Assigned to Neos Therapeutics LP · Expires 2032-06-28 · 6y remaining

Vulnerability score 55/100 Moderate — design-around opportunities exist

What this patent protects

This patent protects a method for making and using dosage forms that provide prolonged therapy, including drug-containing resin particles.

USPTO Abstract

The invention relates to dosage forms that provide prolonged therapy. In particular, the invention relates to dosage forms including various pluralities of drug-containing resin particles. The invention also relates to methods of making these dosage forms and methods of treating using these dosage forms.

Drugs covered by this patent

Patent Metadata

Patent number: US9839619
Jurisdiction: US
Classification: Formulation
Expires: 2032-06-28
Drug substance claim: No
Drug product claim: Yes
Assignee: Neos Therapeutics LP
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.